Benefits Of Oncology Image Collection Reconciliation

By Michael O’Neal, M.D. – Chief Medical Officer, Imaging at Clario

In oncology clinical trials, the quality of medical imaging is pivotal to the success of your therapy. Ongoing imaging assessments during treatment gauge response and serve as the primary endpoint for assessing drug efficacy. Inadequate images or inconsistent quality can lead to missed insights, potentially impacting drug approval.

With biotech companies increasingly seeking expedited regulatory pathways, maintaining consistent, reconciled, and clean data is essential for study efficiency and success. Given the critical role of this data in oncology trials, it's prudent to ensure ongoing correctness in image collection, not just occasional checks. Proactive reconciliation of image scans is especially vital, guaranteeing consistency and accuracy between sponsors and imaging vendors.

Access the full article below to learn how utilizing various tools and technologies can enhance the precision and effectiveness of oncology image reconciliation, ultimately resulting in improved outcomes for cancer patients.